Find Sevabertinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2521285-05-0, 2a7vpm5rwh, Refchem:1098492, Bay-2927088, Bay2927088, Sevabertinib (usan)
Molecular Formula
C24H25ClN4O5
Molecular Weight
484.9  g/mol
InChI Key
VYQVHWNNPKOJEA-AWEZNQCLSA-N
FDA UNII
2A7VPM5RWH

Sevabertinib
Sevabertinib is an orally bioavailable, mutant-selective, dual kinase inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), with potential antineoplastic activity. Upon oral administration, sevabertinib targets, binds to, and inhibits the activity of EGFR and HER2 with exon20 insertion mutations, as well as EGFR with C797X mutations, thereby preventing EGFR- and HER2-mediated signaling. This may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. EGFR and HER2 are receptor tyrosine kinases that play major roles in tumor cell proliferation and tumor vascularization.
1 2D Structure

Sevabertinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(3-chloro-2-methoxyanilino)-2-[3-[[(2S)-1,4-dioxan-2-yl]methoxy]-4-pyridinyl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one
2.1.2 InChI
InChI=1S/C24H25ClN4O5/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-8-27-24(20)30)28-21(22)15-5-7-26-11-19(15)34-13-14-12-32-9-10-33-14/h2-5,7,11,14,28-29H,6,8-10,12-13H2,1H3,(H,27,30)/t14-/m0/s1
2.1.3 InChI Key
VYQVHWNNPKOJEA-AWEZNQCLSA-N
2.2 Other Identifiers
2.2.1 UNII
2A7VPM5RWH
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2521285-05-0

2. 2a7vpm5rwh

3. Refchem:1098492

4. Bay-2927088

5. Bay2927088

6. Sevabertinib (usan)

7. Bay 2927088

8. Sevabertinib [usan]

9. Sevabertinib [inn]

10. Orb2695587

11. Chembl6068074

12. Schembl22588603

13. Gtpl13491

14. Yqf2592

15. Ex-a12844

16. Nsc857380

17. Example 2 [wo2020216781]

18. Nsc-857380

19. (s)-2-(3-((1,4-dioxan-2-yl)methoxy)pyridin-4-yl)-3-((3-chloro-2-methoxyphenyl)amino)-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one

20. Sy458337

21. D13098

22. H50182

23. (s)-2-[3-[(1,4-dioxan-2-yl)methoxy]-4-pyridyl]-3-[(3-chloro-2-methoxyphenyl)amino]-6,7-dihydro-1h-pyrrolo[3,2-c]pyridin-4(5h)-one

24. 3-(3-chloro-2-methoxyanilino)-2-(3-{[(2s)-1,4-dioxan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one

25. 3-(3-chloro-2-methoxyanilino)-2-[3-[[(2s)-1,4-dioxan-2-yl]methoxy]pyridin-4-yl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one

26. 3-[(3-chloro-2-methoxyphenyl)amino]-2-(3-{[(2s)-1,4-dioxan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one

27. 3-[(3-chloro-2-methoxyphenyl)amino]-2-[3-[(2s)-1,4-dioxan-2-yl Methoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one

28. 4h-pyrrolo[3,2-c]pyridin-4-one, 3-[(3-chloro-2-methoxyphenyl)amino]-2-[3-[(2s)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-

2.4 Create Date
2020-12-19
3 Chemical and Physical Properties
Molecular Weight 484.9 g/mol
Molecular Formula C24H25ClN4O5
XLogP32.9
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area107
Heavy Atom Count34
Formal Charge0
Complexity690
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 2521285-05-0 / Sevabertinib API manufacturers, exporters & distributors?

Sevabertinib manufacturers, exporters & distributors 1

38

PharmaCompass offers a list of Sevabertinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sevabertinib manufacturer or Sevabertinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sevabertinib manufacturer or Sevabertinib supplier.

API | Excipient name

Sevabertinib

Synonyms

2521285-05-0, 2a7vpm5rwh, Refchem:1098492, Bay-2927088, Bay2927088, Sevabertinib (usan)

Cas Number

2521285-05-0

Unique Ingredient Identifier (UNII)

2A7VPM5RWH

About Sevabertinib

Sevabertinib is an orally bioavailable, mutant-selective, dual kinase inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), with potential antineoplastic activity. Upon oral administration, sevabertinib targets, binds to, and inhibits the activity of EGFR and HER2 with exon20 insertion mutations, as well as EGFR with C797X mutations, thereby preventing EGFR- and HER2-mediated signaling. This may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. EGFR and HER2 are receptor tyrosine kinases that play major roles in tumor cell proliferation and tumor vascularization.

Sevabertinib Manufacturers

A Sevabertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sevabertinib, including repackagers and relabelers. The FDA regulates Sevabertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sevabertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sevabertinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Sevabertinib Suppliers

A Sevabertinib supplier is an individual or a company that provides Sevabertinib active pharmaceutical ingredient (API) or Sevabertinib finished formulations upon request. The Sevabertinib suppliers may include Sevabertinib API manufacturers, exporters, distributors and traders.

click here to find a list of Sevabertinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Sevabertinib GMP

Sevabertinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sevabertinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sevabertinib GMP manufacturer or Sevabertinib GMP API supplier for your needs.

Sevabertinib CoA

A Sevabertinib CoA (Certificate of Analysis) is a formal document that attests to Sevabertinib's compliance with Sevabertinib specifications and serves as a tool for batch-level quality control.

Sevabertinib CoA mostly includes findings from lab analyses of a specific batch. For each Sevabertinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sevabertinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Sevabertinib EP), Sevabertinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sevabertinib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty